GlassScriptPhysician profile
Heather Hall
NPI 1801814116
$657.22
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $377 · 2023: $250 · 2024: $30.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $281.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $280.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $122.42 | 2023 | Prolia |
| Sunovion Pharmaceuticals INC. | $111.90 | 2021 | |
| Lilly USA, LLC | $75.72 | 2021 | |
| Supernus Pharmaceuticals, INC. | $46.92 | 2021 | |
| Biogen, INC. | $40.58 | 2021 | |
| Abbvie INC. | $39.28 | 2023 | |
| Alexion Pharmaceuticals, INC. | $35.03 | 2021 | |
| Surmodics, INC. | $28.43 | 2023 | Sublime Radial Access Guide Sheath, Sublime Radial Access 018 Rx Pta Dilatation Catheter, Sublime 014 Rx Pta Balloon Dilatation Catheter |
| Teva Pharmaceuticals USA, INC. | $26.71 | 2021 | |
| Boston Scientific Corporation | $23.51 | 2023 | Varithena Administration Pack |
| Corium, LLC | $21.74 | 2023 | Azstarys |
| Ultragenyx Pharmaceutical INC. | $15.80 | 2024 | Crysvita |
| Seqirus USA INC | $15.07 | 2023 | Flucelvax Quadrivalent |
| Sanofi-Aventis U.S. LLC | $14.45 | 2024 | |
| Pfizer INC. | $14.33 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $14.20 | 2021 | |
| Ucb, INC. | $11.13 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.